Mechanistic insights revealed by lipid profiling in monogenic insulin resistance syndromes

Genome Medicine

Volumn 7, Issue 1, 2015, Pages

  Eiden, Michael ^a   Koulman, Albert ^a   Hatunic, Mensud ^b   West, James A ^a,c   Murfitt, Steven ^c   Osei, Michael ^a   Adams, Claire ^b   Wang, Xinzhu ^a,c   Chu, Yajing ^c   Marney, Luke ^a   Roberts, Lee D ^a,c   O'Rahilly, Stephen ^b   Semple, Robert K ^b   Savage, David B ^b   Griffin, Julian L ^a,c  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SATURATED FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; INSR PROTEIN, HUMAN; INSULIN RECEPTOR; LAMIN A; LEUKOCYTE ANTIGEN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; GENE; HUMAN; HUMAN CELL; INSR GENE; INSULIN RESISTANCE; LIPID ANALYSIS; LIPID COMPOSITION; LIPIDOMICS; LIPODYSTROPHY; LIPOGENESIS; LOSS OF FUNCTION MUTATION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; ANIMAL; BLOOD; C57BL MOUSE; CONGENITAL GENERALIZED LIPODYSTROPHY; FEMALE; GENETICS; LIPID DIET; LIVER; METABOLISM; MIDDLE AGED; MOUSE MUTANT; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, CD; DIET, HIGH-FAT; FEMALE; HUMANS; INSULIN RESISTANCE; LAMIN TYPE A; LIPIDS; LIPODYSTROPHY, CONGENITAL GENERALIZED; LIPOGENESIS; LIVER; MALE; MICE, INBRED C57BL; MICE, OBESE; MIDDLE AGED; PPAR GAMMA; RECEPTOR, INSULIN; YOUNG ADULT;

EID: 84939160881     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-015-0179-6     Document Type: Article

References (29)

1. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011;121:1402-11.
2. Kotronen A, Velagapudi VR, Yetukuri L, Westerbacka J, Bergholm R, Ekroos K, et al. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia. 2009;52:684-90.
3. Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation. 2014;129:1821-31.
4. Meikle PJ, Wong G, Barlow CK, Weir JM, Greeve MA, et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One. 2013;8:e7341.
5. Wong G, Barlow CK, Weir JM, Jowett JBM, Magliano DJ, et al. Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes. PLoS One. 2013;8:e76577.
6. Kulkarni H, Meikle PJ, Mamtani M, Weir JM, Almeida M, Diego V, et al. Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families. J Lipid Res. 2014;55:939-46.
7. Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest. 2009;119:315-22.
8. Sleigh A, Raymond-Barker P, Thackray K, Porter D, Hatunic M, Vottero A, et al. Mitochondrial dysfunction in patients with primary congenital insulin resistance. J Clin Invest. 2011;121:2457-61.
9. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78:779-87.
10. Race AM, Styles IB, Bunch J. Inclusive sharing of mass spectrometry imaging data requires a converter for all. J Proteomics. 2012;75:5111-2.
11. Tautenhahn R, Böttcher C, Neumann S. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics. 2008;9:504.
12. MetaboLights. http://www.ebi.ac.uk/metabolights/ .
13. Wiklund S, Johansson E, Sjöström L, Mellerowicz EJ, Edlund U, Shockcor JP, et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem. 2008;80:115-22.
14. Bylesjö M, Eriksson D, Kusano M, Moritz T, Trygg J. Data integration in plant biology: the O2PLS method for combined modeling of transcript and metabolite data. Plant J. 2007;52:1181-91.
15. Eriksson L, Byrne T, Johansson E, Trygg J, Vikstrom C. Multi and megavariate data analysis: basic principles and applications. 3rd ed. Umetrics Academy: Malmo, Sweden; 2013.
16. Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res. 2009;50:574-85.
17. Sanders FWB, Griffin JL. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev. 2015. doi: 10.1111/brv.12178 .
18. Wiegman CH, Bandsma RH, Ouwens M, van der Sluijs FH, Havinga R, Boer T, et al. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes. 2003;52:1081-9.
19. Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes. 2006;55:2159-70.
20. Sevastianova K, Santos A, Kotronen A, Hakkarainen A, Makkonen J, Silander K, et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr. 2012;96:727-34.
21. Aarsland A, Wolfe RR. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. J Lipid Res. 1998;39:1280-6.
22. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343-51.
23. Kaplan ML, Leveille GA. Development of lipogenesis and insulin sensitivity in tissues of the ob/ob mouse. Am J Physiol. 1981;240:E101-7.
24. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL. Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor delta from Peroxisome proliferator-activated receptor gamma in the ob/ob mouse. Genome Med. 2009;1:115.
25. McCombie G, Browning LM, Titman CM, Song M, Shockcor J, Jebb SA, et al. omega-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids. Metabolomics. 2009;5:363-74.
26. Roberts LD, Murray AJ, Menassa D, Ashmore T, Nicholls AW, Griffin JL. The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue. Genome Biol. 2011;12:R75.
27. Ferguson JF, Mulvey CK, Patel PN, Shah RY, Doveikis J, Zhang W, et al. Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers. Mol Nutr Food Res. 2014;58:601-13.
28. Dhanesha N, Joharapurkar A, Shah G, Kshirsagar S, Patel V, Patel K, et al. Treatment with exendin-4 improves the antidiabetic efficacy and reverses hepatic steatosis in glucokinase activator treated db/db mice. Eur J Pharmacol. 2013;714:188-92.
29. Forouhi NG, Koulman A, Sharp SJ, Imamura F, Kröger J, Schulze MB, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2014;2:810-8.